127 related articles for article (PubMed ID: 12712036)
21. Treatment for nerve-poisoning agents.
FDA Consum; 2006; 40(6):6. PubMed ID: 17333555
[No Abstract] [Full Text] [Related]
22. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
23. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
Lai SW; Goldman MP
J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
[TBL] [Abstract][Full Text] [Related]
24. Atropine use in children after nerve gas exposure.
Lynch M
J Pediatr Nurs; 2005 Dec; 20(6):477-84. PubMed ID: 16298290
[No Abstract] [Full Text] [Related]
25. Pretreating rats with parenteral ophthalmic antimuscarinic agents decreases mortality from lethal organophosphate poisoning.
Bryant SM; Rhee JW; Thompson TM; Aks SE
Acad Emerg Med; 2007 Apr; 14(4):370-2. PubMed ID: 17296800
[TBL] [Abstract][Full Text] [Related]
26. Contamination of syringe plungers during the sampling of cyclophosphamide solutions.
Favier B; Gilles L; Latour JF; Desage M; Giammarile F
J Oncol Pharm Pract; 2005 Mar; 11(1):1-5. PubMed ID: 16460597
[TBL] [Abstract][Full Text] [Related]
27. Development of next generation medical countermeasures to nerve agent poisoning.
Wetherell J; Price M; Mumford H; Armstrong S; Scott L
Toxicology; 2007 Apr; 233(1-3):120-7. PubMed ID: 16979808
[TBL] [Abstract][Full Text] [Related]
28. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators.
Krejcova-Kunesova G; Bartosova L; Kuca K
Toxicology; 2005 Dec; 216(1):32-40. PubMed ID: 16126317
[TBL] [Abstract][Full Text] [Related]
29. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes.
Blossom D; Noble-Wang J; Su J; Pur S; Chemaly R; Shams A; Jensen B; Pascoe N; Gullion J; Casey E; Hayden M; Arduino M; Budnitz DS; Raad I; Trenholme G; Srinivasan A;
Arch Intern Med; 2009 Oct; 169(18):1705-11. PubMed ID: 19822828
[TBL] [Abstract][Full Text] [Related]
30. Stability of reconstituted fluconazole oral suspension in plastic bottles and oral syringes.
Dentinger PJ; Swenson CF
Ann Pharmacother; 2009 Mar; 43(3):485-9. PubMed ID: 19208778
[TBL] [Abstract][Full Text] [Related]
31. The cost of maintaining adequate antidote supplies.
Bailey B; Bussières JF
CMAJ; 2001 Nov; 165(11):1467. PubMed ID: 11762566
[No Abstract] [Full Text] [Related]
32. Stability issues of parenteral chemotherapy drugs.
de Lemos ML; Hamata L
J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic preparation time in a horizontal laminar-airflow hood and in a biological-safety cabinet.
Hamm JL; Daniels CE; Somani SM
Am J Hosp Pharm; 1984 Jul; 41(7):1349-51. PubMed ID: 6465149
[TBL] [Abstract][Full Text] [Related]
34. Commercial syringes of atropine: A cost-effective option in the operating room?
Armoiry X; Carry PY; Lehot JJ; Aulagner G; Piriou V
Anaesth Crit Care Pain Med; 2016 Apr; 35(2):177-8. PubMed ID: 26862071
[No Abstract] [Full Text] [Related]
35. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
[TBL] [Abstract][Full Text] [Related]
36. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
[TBL] [Abstract][Full Text] [Related]
37. Pediatric nerve agent poisoning: medical and operational considerations for emergency medical services in a large American city.
Foltin G; Tunik M; Curran J; Marshall L; Bove J; van Amerongen R; Cherson A; Langsam Y; Kaufman B; Asaeda G; Gonzalez D; Cooper A
Pediatr Emerg Care; 2006 Apr; 22(4):239-44. PubMed ID: 16651913
[TBL] [Abstract][Full Text] [Related]
38. Stability of a heparin-free 50% ethanol lock solution for central venous catheters.
Pomplun M; Johnson JJ; Johnston S; Kolesar JM
J Oncol Pharm Pract; 2007 Mar; 13(1):33-7. PubMed ID: 17621565
[TBL] [Abstract][Full Text] [Related]
39. [Nerve gas--guidelines for care of victims of terrorism].
Aas P; Jacobsen D
Tidsskr Nor Laegeforen; 2005 Mar; 125(6):731-5. PubMed ID: 15776066
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
